What This MeiraGTx Insider Sale Signals Momentum Ahead
A MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
New costs require quick yet thoughtful budget tweaks. This section highlights practical adjustments to preserve balance and grow savings.
27,302 articlesA MeiraGTx insider recently sold shares as the biotech nears two pivotal drug filings. This article breaks down what ...
Lemonade's shares swung wildly in a single session, rising on an earnings beat and then tumbling as expectations cool...
As AMD gears up for its July 22 AI event, traders are weighing the risk and reward. This article outlines why the set...
A leading toy company stunned traders with a strong earnings beat, triggering a rapid Friday rally. Learn the key fig...
A WWII pivot from battleships to aircraft carriers and submarines reshaped global power and markets. Today’s investor...
April 2026 data show a 2.4% year-over-year drop in new-home purchase applications, the first annual decline since lat...
A decades‑long pause in U.S. nuclear construction has reshaped the investment landscape, rewarding a utility with a l...
Intuitive Surgical dominates robotic-assisted surgery, and its moat is getting stronger. This piece breaks down why t...
Yatsen's Q1 2026 results are a pivotal signal for the year ahead. This analysis breaks down the earnings narrative, h...
High-end home sellers confront new commission options after the NAR decoupled buyer and seller fees. This report expl...
Markets react as reports surface that the u.s.-iran deal nears, paired with warnings from a Trump ally about Tehran’s...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...